[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Human Insulin Market Report 2017

January 2017 | 102 pages | ID: U9B5540852EEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Human Insulin

Revenue, means the sales value of Human Insulin

This report studies sales (consumption) of Human Insulin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Nono Nordisk
  • Eli Llly
  • Sanofi
  • Merk
  • Tonghua Dongbao
  • Gan Lee
  • United Laboratories
  • Jiangsu Wanbang Biopharmaceuticals
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Regular Human Human Insulin
  • Human Insulin Analogue
Split by applications, this report focuses on sales, market share and growth rate of Human Insulin in each application, can be divided into
  • Short acting
  • Intermediate acting
  • Long acting
  • Pre-mix human insulin
United States Human Insulin Market Report 2017

1 HUMAN INSULIN OVERVIEW

1.1 Product Overview and Scope of Human Insulin
1.2 Classification of Human Insulin
  1.2.1 Regular Human Human Insulin
  1.2.2 Human Insulin Analogue
1.3 Application of Human Insulin
  1.3.1 Short acting
  1.3.2 Intermediate acting
  1.3.3 Long acting
  1.3.4 Pre-mix human insulin
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Human Insulin (2011-2021)
  1.4.1 United States Human Insulin Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Insulin Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN INSULIN COMPETITION BY MANUFACTURERS

2.1 United States Human Insulin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Insulin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Insulin Average Price by Manufactures (2015 and 2016)
2.4 Human Insulin Market Competitive Situation and Trends
  2.4.1 Human Insulin Market Concentration Rate
  2.4.2 Human Insulin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN INSULIN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Human Insulin Sales and Market Share by States (2011-2016)
3.2 United States Human Insulin Revenue and Market Share by States (2011-2016)
3.3 United States Human Insulin Price by States (2011-2016)

4 UNITED STATES HUMAN INSULIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Human Insulin Sales and Market Share by Type (2011-2016)
4.2 United States Human Insulin Revenue and Market Share by Type (2011-2016)
4.3 United States Human Insulin Price by Type (2011-2016)
4.4 United States Human Insulin Sales Growth Rate by Type (2011-2016)

5 UNITED STATES HUMAN INSULIN SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Human Insulin Sales and Market Share by Application (2011-2016)
5.2 United States Human Insulin Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN INSULIN MANUFACTURERS PROFILES/ANALYSIS

6.1 Nono Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Insulin Product Type, Application and Specification
    6.1.2.1 Regular Human Human Insulin
    6.1.2.2 Human Insulin Analogue
  6.1.3 Nono Nordisk Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Eli Llly
  6.2.2 Human Insulin Product Type, Application and Specification
    6.2.2.1 Regular Human Human Insulin
    6.2.2.2 Human Insulin Analogue
  6.2.3 Eli Llly Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Human Insulin Product Type, Application and Specification
    6.3.2.1 Regular Human Human Insulin
    6.3.2.2 Human Insulin Analogue
  6.3.3 Sanofi Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Merk
  6.4.2 Human Insulin Product Type, Application and Specification
    6.4.2.1 Regular Human Human Insulin
    6.4.2.2 Human Insulin Analogue
  6.4.3 Merk Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Tonghua Dongbao
  6.5.2 Human Insulin Product Type, Application and Specification
    6.5.2.1 Regular Human Human Insulin
    6.5.2.2 Human Insulin Analogue
  6.5.3 Tonghua Dongbao Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Gan Lee
  6.6.2 Human Insulin Product Type, Application and Specification
    6.6.2.1 Regular Human Human Insulin
    6.6.2.2 Human Insulin Analogue
  6.6.3 Gan Lee Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 United Laboratories
  6.7.2 Human Insulin Product Type, Application and Specification
    6.7.2.1 Regular Human Human Insulin
    6.7.2.2 Human Insulin Analogue
  6.7.3 United Laboratories Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Jiangsu Wanbang Biopharmaceuticals
  6.8.2 Human Insulin Product Type, Application and Specification
    6.8.2.1 Regular Human Human Insulin
    6.8.2.2 Human Insulin Analogue
  6.8.3 Jiangsu Wanbang Biopharmaceuticals Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview

7 HUMAN INSULIN MANUFACTURING COST ANALYSIS

7.1 Human Insulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Insulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Insulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Insulin Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN INSULIN MARKET FORECAST (2016-2021)

11.1 United States Human Insulin Sales, Revenue Forecast (2016-2021)
11.2 United States Human Insulin Sales Forecast by Type (2016-2021)
11.3 United States Human Insulin Sales Forecast by Application (2016-2021)
11.4 Human Insulin Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Human Insulin
Table Classification of Human Insulin
Figure United States Sales Market Share of Human Insulin by Type in 2015
Figure Regular Human Human Insulin Picture
Figure Human Insulin Analogue Picture
Table Application of Human Insulin
Figure United States Sales Market Share of Human Insulin by Application in 2015
Figure Short acting Examples
Figure Intermediate acting Examples
Figure Long acting Examples
Figure Pre-mix human insulin Examples
Figure United States Human Insulin Sales and Growth Rate (2011-2021)
Figure United States Human Insulin Revenue and Growth Rate (2011-2021)
Table United States Human Insulin Sales of Key Manufacturers (2015 and 2016)
Table United States Human Insulin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Insulin Sales Share by Manufacturers
Figure 2016 Human Insulin Sales Share by Manufacturers
Table United States Human Insulin Revenue by Manufacturers (2015 and 2016)
Table United States Human Insulin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Insulin Revenue Share by Manufacturers
Table 2016 United States Human Insulin Revenue Share by Manufacturers
Table United States Market Human Insulin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Insulin Average Price of Key Manufacturers in 2015
Figure Human Insulin Market Share of Top 3 Manufacturers
Figure Human Insulin Market Share of Top 5 Manufacturers
Table United States Human Insulin Sales by States (2011-2016)
Table United States Human Insulin Sales Share by States (2011-2016)
Figure United States Human Insulin Sales Market Share by States in 2015
Table United States Human Insulin Revenue and Market Share by States (2011-2016)
Table United States Human Insulin Revenue Share by States (2011-2016)
Figure Revenue Market Share of Human Insulin by States (2011-2016)
Table United States Human Insulin Price by States (2011-2016)
Table United States Human Insulin Sales by Type (2011-2016)
Table United States Human Insulin Sales Share by Type (2011-2016)
Figure United States Human Insulin Sales Market Share by Type in 2015
Table United States Human Insulin Revenue and Market Share by Type (2011-2016)
Table United States Human Insulin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Insulin by Type (2011-2016)
Table United States Human Insulin Price by Type (2011-2016)
Figure United States Human Insulin Sales Growth Rate by Type (2011-2016)
Table United States Human Insulin Sales by Application (2011-2016)
Table United States Human Insulin Sales Market Share by Application (2011-2016)
Figure United States Human Insulin Sales Market Share by Application in 2015
Table United States Human Insulin Sales Growth Rate by Application (2011-2016)
Figure United States Human Insulin Sales Growth Rate by Application (2011-2016)
Table Nono Nordisk Basic Information List
Table Nono Nordisk Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Nono Nordisk Human Insulin Sales Market Share (2011-2016)
Table Eli Llly Basic Information List
Table Eli Llly Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Llly Human Insulin Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Human Insulin Sales Market Share (2011-2016)
Table Merk Basic Information List
Table Merk Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merk Human Insulin Sales Market Share (2011-2016)
Table Tonghua Dongbao Basic Information List
Table Tonghua Dongbao Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tonghua Dongbao Human Insulin Sales Market Share (2011-2016)
Table Gan Lee Basic Information List
Table Gan Lee Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gan Lee Human Insulin Sales Market Share (2011-2016)
Table United Laboratories Basic Information List
Table United Laboratories Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Laboratories Human Insulin Sales Market Share (2011-2016)
Table Jiangsu Wanbang Biopharmaceuticals Basic Information List
Table Jiangsu Wanbang Biopharmaceuticals Human Insulin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Wanbang Biopharmaceuticals Human Insulin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Insulin
Figure Manufacturing Process Analysis of Human Insulin
Figure Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Human Insulin Major Manufacturers in 2015
Table Major Buyers of Human Insulin
Table Distributors/Traders List
Figure United States Human Insulin Production and Growth Rate Forecast (2016-2021)
Figure United States Human Insulin Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Insulin Production Forecast by Type (2016-2021)
Table United States Human Insulin Consumption Forecast by Application (2016-2021)
Table United States Human Insulin Sales Forecast by States (2016-2021)
Table United States Human Insulin Sales Share Forecast by States (2016-2021)


More Publications